Robert A. Stoltz
New York Medical College
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert A. Stoltz.
Biochimica et Biophysica Acta | 1994
Satoru Yamamoto; Motonubu Nishimura; Michael S. Conners; Robert A. Stoltz; John R. Falck; Kamlesh Chauhan; Michal Laniado-Schwartzman
The R and S enantiomers of 12-hydroxyeicosatetraenoic acid (12-HETE) exhibit different biological activities. Although they appear to be produced by different enzymatic pathways, cytochrome P-450 monooxygenase and lipoxygenase, respectively, they display similar metabolism in both corneal epithelium and neutrophils. In corneal epithelial microsomes, both enantiomers are subject to oxidation and keto reduction reactions to form the dihydro metabolite, 12-hydroxy-5,8,14-eicosatrienoic acid (12-HETrE), via a keto intermediate. The apparent Km for the formation of 12-HETrE was 17.9 and 20 microM for 12(R)-HETE and 12(S)-HETE, respectively, and the apparent Vmax of the reaction was 17.4 and 8.2 pmol/mg per min, respectively. Chiral analysis of the dihydro metabolite demonstrated a product enantiospecificity. Arachidonic acid, 12(R)-HETE, 12(S)-HETE and the intermediate of this reaction, 12-oxo-ETrE, were metabolized predominantly to 12(R)-HETrE in a ratio [12(R)-HETrE: 12(S)-HETrE] of 7.3:1, 4.3:1, 1.5:1 and 2.3:1, respectively. 12(R)-HETrE is a potent vasodilator, chemotactic and angiogenic factor whose synthesis is induced in inflamed tissues; 12(S)HETrE is devoid of these properties. 12(R)-HETE, derived from NADPH-dependent cytochrome P-450 monooxygenases, and 12(S)-HETE, derived from 12-lipoxygenase, may both play an important role in regulating the inflammatory response by serving as substrates for the local synthesis of 12(R)-HETrE.
Bioorganic & Medicinal Chemistry Letters | 1994
Kamlesh Chauhan; Dhamjewar Ravi; John R. Falck; Robert A. Stoltz; Michal Laniado-Schwartzman
Abstract The title autacoids and acetylenic analogs were conveniently prepared from 2-deoxy- D -ribose via Barton deoxygenation, cuprate coupling, and Wittig homologation. 12(R)-HETrE, but not the 12(S)-isomer, significantly stimulated microvessel endothelial cell proliferation and proto-oncogene mRNA levels at sub-nano to picomolar concentrations. A high affinity binding site for 12(R)-HETrE was detected on microvessle endothelial cells.
Investigative Ophthalmology & Visual Science | 1995
Michael S. Conners; Robert A. Stoltz; K L Davis; Michael W. Dunn; Nader G. Abraham; Richard D. Levere; Michal Laniado-Schwartzman
Investigative Ophthalmology & Visual Science | 1997
Michael S. Conners; F Urbano; C Vafeas; Robert A. Stoltz; Michael W. Dunn; Michal Laniado Schwartzman
Investigative Ophthalmology & Visual Science | 1995
Michael S. Conners; Robert A. Stoltz; S C Webb; J Rosenberg; Michael W. Dunn; Nader G. Abraham; Michal Laniado-Schwartzman
Journal of Biological Chemistry | 1994
Michal Laniado-Schwartzman; Yan Lavrovsky; Robert A. Stoltz; Michael S. Conners; John R. Falck; Kamlesh Chauhan; Nader G. Abraham
Journal of Ocular Pharmacology and Therapeutics | 1995
Teresa K. Neil; Robert A. Stoltz; Samuel Jiang; Michal Laniado-Schwartzman; Michael W. Dunn; Richard D. Levere; Atallah Kappas; Nader G. Abraham
Current Eye Research | 1997
Jean-Louis da Silva; Robert A. Stoltz; Michael W. Dunn; Nader G. Abraham; Shigaki Shibahara
Journal of Ocular Pharmacology and Therapeutics | 1994
Robert A. Stoltz; Michael S. Conners; Michael W. Dunn; Michal Laniado Schwartzman
Journal of Ocular Pharmacology and Therapeutics | 1997
Robert A. Stoltz; Michal Laniado Schwartzman